Nesfatin-1, an anorexic neuropeptide discovered in 2006, is widely distributed in the central
nervous system and peripheral tissues. It has been shown to be involved in the regulation of …

Since the discovery of Nesfatin-1 in 2006, intensive research was finalized to further and
deeper investigate the precise physiological functions of the peptide at both central and …

Background Nesfatin-1, a novel adipokine and dipeptidyl peptidase-4 (DPP4), a mam
malian serine protease, are potent factors of atherosclerosis. In the present cross-sectional …

Coronary slow flow phenomenon (CSFP) is a coronary artery disease in which coronary
angiography shows no obvious stenosis, but there is a delay in blood flow perfusion. The …

Nesfatin-1 was discovered as an anorexigenic peptide derived from proteolytic cleavage of
the prepropeptide, nucleobindin 2 (NUCB2). It is widely expressed in central as well as …

Objectives. Nesfatin-1 is a novel anorectic neuropeptide with potent metabolic regulatory
effects. Nesfatin-1 regulates blood pressure, heart rate, cardiomyocyte metabolism, and …

We evaluated the relationship between nesfatin-1 and acute myocardial infarction (AMI) and
Mediterranean diet scores. 67 patients with AMI and 33 patients with normal coronary …

Introduction: Ischaemic stroke (IS) is a disease that is a common cause of death and one of
the most common causes of disability in adults. There is a continuous need to conduct stroke …

Background: Nesfatin, as an adipokine, has been shown to have a number of metabolic
effects associated with a variety of inflammatory diseases. Objectives: The current study …

OBJECTIVES: Nesfatin-1 is an antiiflammatory, antiapoptotic, and anorexigenic peptide that
has many roles in cardiomyocyte metabolism and viability. Inflammation plays an important …